NEW YORK - Medical marijuana dispensaries could open in New York state next week, but patients may still be waiting to get access. The Compassionate Care Act, signed into law in July of last year, set Jan. 5, 2016 as a target date for up to 20 dispensaries to open statewide.
But Julie Netherland of the Drug Policy Alliance says the state Department of Health didn't launch the system to register and train doctors until last October and patient registration just opened last week.
"So that leaves patients very little time to find a physician, to get certified by that physician and then to apply to the state Department of Health for a patient ID card," says Netherland.
The Department of Health also has not published a list of doctors trained to certify medical marijuana patients, making it difficult for patients to identify a qualified physician.
Since the state passed its medical marijuana law, Beverly McClain, a cancer patient who championed the bill, has died without ever being certified to use the drug. And Netherland points out that access can literally be a matter of life or death to some children who have a severe form of epilepsy.
"Medical marijuana, in some cases, can really reduce both the number and severity of those seizures," she says. "And that can be life saving for these young kids because any one of these seizures can take their life."
Netherland says at least three children have died from epileptic seizures in New York in the past 18 months.
New York only lists 10 illnesses that qualify for medical marijuana and restricts the forms available to capsules, oils and liquids. Smoking and edible products are not allowed. And there will only be 20 dispensaries in a state with 20 million people covering 54,000 square miles. Netherland maintains that regulating medical marijuana is necessary, but of the 23 states that allow its use, New York is one of the most restrictive.
"What we've seen in New York is they have tipped the scales too far and over-regulated the program to such a degree that it really can restrict patient access," Netherland says.
Last month Gov. Andrew Cuomo signed the Medical Marijuana Emergency Access bill, intended to get marijuana to critically ill patients more quickly. But the Drug Policy Alliance says so far there's no indication that the law has had any impact.
get more stories like this via email
Toughing it out during spring allergy season is not in your best interest if you want to avoid asthma later in life.
New Mexico has plenty of grass and weed pollens carried by the wind which contribute to itchy, watery eyes, a stuffy nose and sneezing fits this time of year.
Dr. Osman Dokmeci, associate professor of internal medicine at the University of New Mexico, suggested for those who suffer acutely, seek an allergy test and possibly medication to prevent asthma from taking hold.
"One out of 10 has asthma in America," Dokmeci pointed out. "Having seasonal allergies increases your chance of developing asthma at least fivefold."
He recommended treating allergies early and as aggressively as possible. May is "Asthma Awareness Month," which aims to bring attention to the health issue and highlight improvements in care and quality of life. Nationwide, asthma affects more than 25 million Americans, including 4 million children, and disproportionately affects certain racial and ethnic groups.
Allergies do not "cause" asthma but people who have allergies, or have family members who have allergies, are more likely to get asthma than those who do not. Research shows allergy season is starting earlier and lasting longer. A 2022 study from the University of Michigan found pollen count could increase by 200% by the end of the century due to climate change, which is why Dokmeci stressed it is important not to ignore the problem.
"There's no treatment that actually makes your asthma not happen," Dokmeci explained. "But once you develop asthma, there are good treatment options."
The estimated economic impact of asthma is more than $80 billion per year from direct and indirect costs, such as missed school and workdays.
get more stories like this via email
Recent research shows approximately half of people who die by suicide had contact with a health care professional within the month prior to their death.
However, a recent study shows only 8% of hospitals are currently implementing all four recommended suicide prevention practices: safety planning, warm handoffs to outpatient care, patient follow-up and lethal means counseling.
Melissa Tolstyka, director of Behavioral Health Services for Trinity Health Ann Arbor, said a seamless transition from inpatient to outpatient care is critical. At Ann Arbor, she saw a 46% increase in compliance with comprehensive suicide risk assessments and patients discharged on the suicide care pathway now receive a safety plan, which she sees as progress.
"We continue to see a need for really robust programming," Tolstyka explained. "Not just within the behavioral health world, but in the medical world as well. Our organization really wanted to focus on bringing the behavioral health and the medical services together to enhance our safer suicide care practices for our patients."
The initiative is being piloted across various units at Trinity Hospitals in Ann Arbor and Grand Rapids including the emergency department, psychiatric medical and inpatient nursing units. If you or anyone you know is struggling or in crisis, help is available 24 hours a day, seven days a week, by calling or texting 988, the Suicide and Crisis Lifeline.
Casie Sultana, clinical nurse leader for Trinity Health Grand Rapids, prioritizes patient well-being, emphasizing support and improvement over solely managing risks within the facility.
"We want to be someplace that people feel welcome to come to who are dealing with suicide," Sultana emphasized. "You feel so alone. It's a very lonely journey and we want people to come seek help and feel welcomed when they do that."
Susan Burchardt, clinical services manager at Trinity Grand Rapids, advised other hospitals considering a similar program to learn from organizations already using it.
Support for this reporting was provided by The Pew Charitable Trusts.
get more stories like this via email
Access to reduced-price medication is a necessity for many rural Missourians with low income.
Rep. Cindy O'Laughlin, R-Shelbina, the Senate Floor Leader, said Big Pharma is trying to confuse legislators with unrelated hot-button topics such as abortion access and illegal immigration in a last-ditch effort to stop the state from joining a program to force drugmakers to sell medicines at a discount.
"Appealing to nuclear topics, which really do not apply in this situation, is a disingenuous way to try to defeat a bill that is actually good for Missouri," O'Laughlin asserted.
O'Laughlin pointed out the program is transparent, and uses the tax money saved to help low-income families deal with chronic conditions such as diabetes.
The drugmakers object to the government forcing them to give significant discounts, arguing hospitals' and for-profit pharmacies' bottom lines, particularly those owned by pharmacy benefits managers, are being exploited. Nationally, 46% of contract pharmacy agreements involve pharmacies linked to the three largest benefits managers.
Rep. Tara Peters, R-Rolla, introduced the 340B contract pharmacy access billand said the lobbying is absurd.
"Federally, 340B program does not allow for abortion drugs," Peters stressed. "Why would any legislation that we're trying to pass in the state allow for that? I mean, the thought of that even being in existence is absolutely ludicrous."
The Missouri Senate passed the bill 27-3 on Monday and it now goes to the House.
get more stories like this via email